Now I have full verification. Let me construct the final consolidated review.

## Summary

This paper uses controlled dropout variation (p=0 to 0.9) across 10 AlexNet models to operationalize the sparse-to-distributed coding continuum. It shows that increasing dropout systematically reduces representational dimensionality (eigenspectrum decay rate α), preserves task performance within 10%, and reveals a robustness optimum at p=0.7 under simulated lesions. The paper further claims that this same p=0.7 model achieves maximal emergent alignment with human OTC representations (measured via classical RSA on 7T fMRI from the Natural Scenes Dataset) and exhibits a spectral decay rate that most closely matches human OTC (~α=1.13). The core thesis is that dropout manipulation reveals an optimal tradeoff between efficiency (high-dimensional sparse codes) and robustness (low-dimensional distributed codes) that is shared between artificial and biological vision.

## Strengths

- **Clean experimental manipulation with systematic control**: The paper varies a single inductive bias (dropout probability p) across 10 models while holding all other training parameters constant (learning rate schedule, batch size, optimizer, no weight decay). Figure 1D shows that this manipulation produces a monotonic, interpretable shift in representational dimensionality (α values), confirming that dropout proportion is an effective causal knob for eigenspectral properties. This is more controlled than prior work (e.g., Stringer et al., 2019) which could only correlate spectral properties with behavior in fixed neural data.

- **Task performance is preserved across the manipulation**: All 10 models maintain top-5 ImageNet accuracy within a 10% range (Figure 2A), with peak accuracy at the canonical p=0.5 used in original AlexNet. This rules out the trivial explanation that the representational effects are driven by models simply failing to learn the task, strengthening the inference that the observed spectral and robustness differences reflect genuine coding strategy variation.

- **Lesion robustness results with error bars and clear inflection point**: The lesion analysis (Figure 2C-D) uses 10 random iterations per condition with reported standard deviation, showing a clear non-monotonic pattern where robustness increases up to p=0.7 and then declines. The observation that the optimal robustness model (p=0.7) differs from the highest-accuracy model (p=0.5) is a genuine empirical finding that suggests a dissociation between task performance and robustness.

- **Extension of spectral coding analysis from mouse V1 to human OTC**: The paper applies denoised eigenspectrum estimation to human high-level visual cortex (OTC), going beyond prior work limited to rodent early visual cortex. The human OTC α estimate (mean=1.13, SD=0.05 over 8 subjects) provides a new quantitative benchmark for the spectral properties of object representations in the ventral stream.

## Weaknesses

### Major

- **Brain RSA results lack any statistical inference (Section 2.4, Figure 3C)**: The paper's central claim—that p=0.7 produces maximal emergent brain alignment—is presented without confidence intervals, error bars, p-values, or any test of whether the difference between p=0.7 and adjacent conditions (p=0.6, p=0.8) is statistically significant. The paper reports only point estimates of Pearson r for each model across 8 subjects. Given that classical RSA (unweighted) typically produces modest correlations, it is entirely possible that the apparent optimum at p=0.7 is within the noise range of the measurements. Without subject-level bootstrapped intervals or a repeated-measures comparison (e.g., model × subject ANOVA or permutation test), the claim of "maximal emergent neural predictivity" at p=0.7 is unsupported. This is the most serious weakness because the brain alignment result is the paper's headline finding and is invoked in the title ("biological ... visual systems").

- **Brain eigenspectrum comparison is qualitative and relies on an unvalidated method (Section 2.5)**: The GSN method for denoised eigenspectrum estimation is cited to a forthcoming manuscript ("cvnlab, 2022, to be fully described and validated in a forthcoming manuscript"). It is not compared against the established alternative (Stringer et al.'s cvPCA), and no validation is provided that the denoised spectra are stable or meaningful for this dataset. Furthermore, the claim that p=0.7's α "most closely matched" human OTC is purely qualitative—the paper reports human OTC α (mean 1.13, SD 0.05) and shows bar plots in Figure 3E, but provides no formal distance metric, no test of whether the p=0.7 model's α is significantly closer to the human values than other models' α, and no quantification of match quality (e.g., mean squared error across models vs. each subject). This limits the spectral evidence to a qualitative observation rather than a rigorous test.

- **Lesion robustness normalization may confound baseline differences (Section 2.3, Figure 2C-D)**: Robustness is reported as "percent of baseline top-5 accuracy." Because baseline accuracy varies across models (p=0 earns ~80%, p=0.9 earns ~70%, as shown in Figure 2A), this normalization can inflate the apparent robustness of lower-performing models relative to higher-performing ones. The paper does not report absolute post-lesion accuracy alongside the normalized values, making it difficult to verify whether the observed optimum at p=0.7 is robust to the choice of normalization. While the baseline variation is only ~10%, this is a genuine methodological gap that should be addressed.

### Minor

- **Representational Trajectory Analysis lacks quantitative support (Section 2.2)**: The 2D MDS visualization in Figure 2B is described qualitatively ("systematic variations in representational geometries"). No quantitative measure of trajectory divergence is provided (e.g., pairwise distances between trajectories as a function of dropout, Procrustes analysis, or stress values for the MDS projection). This limits the analysis to a visual observation.

- **No variance-explained metric for RSA results**: The RSA correlations are described as Pearson r values, but r² (variance explained) is not reported. Given that classical RSA correlations are typically modest, reporting r² would help readers calibrate how much OTC representational variance these models actually capture, which is important context for the "maximal alignment" claim.

- **No within-dropout replication**: A single model per dropout level was trained. Adding a second seed per condition would provide an estimate of representational variance within a dropout level, strengthening the inference that observed differences across dropout levels exceed within-level variability.

- **The mapping between "sparse-to-distributed" and dimensionality is asserted, not directly measured**: The paper treats high α (fast decay) = low-dimensional = distributed, and low α (slow decay) = high-dimensional = sparse. While plausible, this mapping conflates dimensionality (measured by α) with sparsity per se. A direct measure of population sparsity (e.g., lifetime sparsity, fraction of silent units) would strengthen the link between the dropout manipulation and the claimed coding continuum.

### Trivial

- Typo: "seperately" should be "separately" (line 158).

## Nice-to-Haves

- Include subject-level bootstrapped confidence intervals for the RSA correlations in Figure 3C — this would directly address the most critical evidentiary gap without requiring new data.
- Report absolute post-lesion accuracy alongside normalized values.
- For the spectral comparison, compute the absolute difference between each model's α and each subject's OTC α, and test whether this distance is minimized at p=0.7 (e.g., via a permutation test or repeated-measures analysis).
- Compare GSN results against cvPCA (Stringer et al., 2019) on the same data as a validation check.

## Removed Points

These points from the reviewers were removed or weakened after cross-checking against the paper:

1. **Harsh Critic: "No control for potential confounds — other hyperparameters held fixed"** — REMOVED. Holding all other hyperparameters constant while varying only dropout is precisely the design of a controlled experiment. The entire point is to isolate the effect of dropout. Criticizing this as a confound reflects a misunderstanding of the experimental design.

2. **Harsh Critic: "r ≈ 0.055–0.068" specific values** — REMOVED. These specific numbers do not appear in the paper text. While the reviewer may be estimating from the figure, the exact values cannot be verified from the text, and the core criticism (lack of statistics) is retained in the Major section without relying on unverifiable numbers.

3. **Harsh Critic: "Lesion analysis uses random unit removal which does not resemble structured brain lesions"** — REMOVED. The paper explicitly positions this as a simulated lesion paradigm drawing on the neuropsychological tradition. Random unit removal is a standard, well-motivated first approach. Criticizing the absence of structured lesions is scope creep.

4. **Strength Finder: Strength 2 ("Optimal lesion robustness at p=0.7 coincides with maximal emergent brain alignment")** — DOWNGRADED from core strength. This claim conflicts with the verified major weakness (lack of statistical support for the brain RSA results). It is retained as a claimed finding but the evidentiary support is insufficient to call it a strength.

5. **Strength Finder: Strength 3 ("Denoised eigenspectrum comparison reveals quantitative match")** — DOWNGRADED. The match is qualitative, not quantitative, and relies on an unvalidated method.

6. **Harsh Critic: "The relationship between sparse-to-distributed and low/high dimensionality is conflated"** — MOVED to Minor. This is a conceptual nuance worth noting but does not invalidate the results; the paper's interpretation is standard in the literature and acknowledged to be a mapping rather than an identity.

## Novel Insights

None beyond the paper's own contributions. The reviewers identify genuine gaps (lack of statistics, qualitative comparisons) but do not uncover contradictions or unexpected patterns that the paper itself missed.

## Suggestions

The highest-leverage action is to compute bootstrapped confidence intervals and a statistical test (e.g., repeated-measures ANOVA or permutation test comparing p=0.7 against adjacent levels) for the RSA brain alignment results. This single addition would either salvage or refute the paper's central claim and requires no new data. Second, report absolute post-lesion accuracy alongside the normalized values to address the normalization concern. Third, quantify the spectral match using a distance metric (e.g., absolute difference in α or mean squared error across eigenvalues). These three changes are internal to the existing data and would determine whether the paper's headline claims hold up to statistical scrutiny.

## Score and Decision

The paper's experimental design (controlled dropout manipulation, dimensionality characterization, lesion analysis, brain comparison) is well-structured and poses an interesting question. The finding that dropout systematically alters spectral decay is solid. However, the paper's central claims—that p=0.7 represents an optimal balance and that this optimum is reflected in human brain representations—are not adequately supported by the evidence as presented. The RSA results lack any statistical testing, the spectral comparison is qualitative and uses an unvalidated method, and the lesion normalization has a potential confound. These are not fatal flaws (the data exist to address them), but they are major gaps in the current submission.

**Score**: 5.5
**Decision**: Reject

The paper has a clear path to revision: add proper statistical analyses, report absolute lesion accuracy, and quantify the spectral match. If these confirm the p=0.7 optimum, the paper would make a solid contribution. In its current form, the strength of the claims exceeds the strength of the evidence.

MY FINAL SCORE: <score>5.5</score>
MY FINAL DECISION: <decision>Reject</decision>